Publication: Orbital pseudotumor: Clinical features and outcomes
Issued Date
2007-12-01
Resource Type
ISSN
0125877X
Other identifier(s)
2-s2.0-40749135919
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology. Vol.25, No.4 (2007), 215-218
Suggested Citation
Niphon Chirapapaisan, Wanicha Chuenkongkaew, Kanograt Pornpanich, Sumalee Vangveeravong Orbital pseudotumor: Clinical features and outcomes. Asian Pacific Journal of Allergy and Immunology. Vol.25, No.4 (2007), 215-218. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/24477
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Orbital pseudotumor: Clinical features and outcomes
Other Contributor(s)
Abstract
To describe the clinical characteristics of orbital pseudotumor, a retrospective analysis was performed on patients with orbital pseudotumor at Siriraj Hospital for ten years. Forty-nine patients (24 males and 25 females; 62 eyes) with a mean age of 43.75 years were included (a mean follow-up of 25 months). Thirty-six patients (73.5%) had unilateral disease. The clinical features were proptosis (79.6%), ocular motor deficit (61.2%), pain (51%), lid swelling or lid mass (44.9%), ptosis (24.5%), and chemosis (18.4%). The most common presenting sign was proptosis (49%). All were treated with corticosteroids with clinical improvement in 40 (81.6%) patients. Ten (83.3%) of 12 patients with visual loss improved with mean recovery time of 10.3 days. Ocular motility recovered in 24 (80%) patients, occurring an average of 17.8 days after initiation of therapy. It is concluded that the clinical features of orbital pseudotumor are varied. Most patients were improved with corticosteroids treatment.